Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion evidence source_evidence_literature NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion SIO_000772 15342407 NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion wasDerivedFrom befree-20140225 NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion wasGeneratedBy ECO_0000203 NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.